indican has been researched along with Colitis Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Buechler, C; Elger, T; Fererberger, T; Gunawan, S; Huss, M; Kandulski, A; Liebisch, G; Loibl, J; Müller, M; Sommersberger, S; Tews, HC | 1 |
1 other study(ies) available for indican and Colitis Gravis
Article | Year |
---|---|
Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity.
Topics: Acetates; Biomarkers; Butyrates; Chromatography, Liquid; Colitis, Ulcerative; Crohn Disease; Fatty Acids, Volatile; Feces; Humans; Indican; Inflammatory Bowel Diseases; Isobutyrates; Leukocyte L1 Antigen Complex; Patient Acuity; Propionates; Tandem Mass Spectrometry | 2023 |